- Home
- WBX vs PRQR Comparison
WBX vs PRQR Comparison
Compare WBX & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WBX | PRQR |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | Spain | Netherlands |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.0M | 250.7M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | WBX | PRQR |
|---|---|---|
| Price | $3.13 | $2.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $9.00 | $8.14 |
| AVG Volume (30 Days) | 40.3K | ★ 586.4K |
| Earning Date | 02-26-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $174,593,453.00 | $18,859,556.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.11 | $19.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.30 | $1.07 |
| 52 Week High | $14.40 | $3.10 |
Technical Indicators
Market Signals| Indicator | WBX | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 53.19 | 51.88 |
| Support Level | $2.30 | $1.92 |
| Resistance Level | $3.36 | $2.31 |
| Average True Range (ATR) | 0.18 | 0.15 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 87.37 | 66.71 |
Price Performance
Historical ComparisonAbout WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.